サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1375885

予防ヘルスケア技術とサービスの市場規模、シェア、動向分析レポート：タイプ別、地域別、セグメント予測、2023年～2030年

Preventive Healthcare Technologies And Services Market Size, Share & Trends Analysis Report By Type (Early Detection & Screening, Chronic Disease Management, Vaccines), By Region, And Segment Forecasts, 2023 - 2030

出版日
ページ情報
英文 80 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
予防ヘルスケア技術とサービスの市場規模、シェア、動向分析レポート：タイプ別、地域別、セグメント予測、2023年～2030年
出版日: 2023年10月05日
発行: Grand View Research
ページ情報: 英文 80 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

予防ヘルスケア技術とサービス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の予防ヘルスケア技術とサービス市場規模は、2023年から2030年にかけて11.8%のCAGRを記録し、2030年までに5,856億米ドルに達すると予測されています。

市場拡大を促進する主な要因には、生活の質、寿命を向上させ、ヘルスケア支出を最小限に抑える予防対策に対する意識の高まりがあります。

この市場の成長は、先進技術の採用や、医療ミスを減らすためのワクチン、スクリーニング＆モニタリング装置、スマート装置などの予防手段の開発に起因しています。また、出生率の低下により、慢性疾患にかかりやすい老年人口が増加していることなども、市場の成長を後押ししています。

2010年以降、人間開発指数（HDI）の評価が導入され、すべての国が自国と国民の全体的な発展に取り組んでいます。平均寿命はHDIの計算に大きな影響を与えます。各国政府は、無料または手ごろな価格の予防接種、禁煙、手ごろな価格の保険制度など、さまざまなプログラムを実施することで、国民の平均寿命の改善に力を入れています。これらのプログラムは、予防可能な技術やサービス分野に直接的な好影響をもたらします。

予防ヘルスケアの大部分には、早期発見とスクリーニング技術が含まれます。この分野は個別化診断技術に関連しており、診断の正確性と革新的技術の利用可能性により、最大のシェアを獲得しています。

予防ヘルスケア技術とサービス市場レポートハイライト：

  • WHOが発表したデータによると、米国における予防接種の割合は増加しています。予防接種には、政府による資金提供のものと民間購入のものが含まれます。
  • 2022年には、早期発見・スクリーニング技術分野が最大のシェアを占める。個別化医療技術に関連する利点、例えば精度の高さや可能性のある疾患や障害の早期発見などが、このセグメントの最大シェアの主な要因です。
  • 先進技術のイントロダクションと正確なスクリーニング方法に対する需要の高まりにより、早期発見とスクリーニングの成長が予測期間中に最も速くなると予想されます。
  • 北米が2022年に40.4％の最大収益シェアで市場を独占しました。
  • 経済成長と政府の取り組みがアジア太平洋地域の成長を促進すると予想されます。同分野は予測期間中14.2％以上の有利なCAGRが見込まれます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 予防ヘルスケア技術およびサービス市場の変数、動向および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 予防ヘルスケア技術およびサービス市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 予防ヘルスケア技術およびサービス市場：タイプ推定・動向分析

  • 予防ヘルスケア技術およびサービス市場：重要なポイント
  • 予防ヘルスケア技術およびサービス市場：動向および市場シェア分析、2022年および2030年
  • 早期発見およびスクリーニング技術
  • 慢性疾患管理技術
  • ワクチン
  • エラーを減らすための高度なテクノロジー

第5章 予防ヘルスケア技術およびサービス市場：地域推定・動向分析

  • 地域別の見通し
  • 地域別の予防ヘルスケア技術およびサービス市場：重要なポイント
  • 北米
    • 北米市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 欧州市場推計・予測、2018～2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • アジア太平洋市場推計・予測、2018～2030年
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ラテンアメリカ市場推計・予測、2018～2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • MEA市場推計・予測、2018年から2030年
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • Myriad Genetics, Inc.
    • Quest Diagnostics Incorporated
    • Medtronic
    • Abbott
    • Merck & Co., Inc.
    • GSK plc
    • Omnicell
    • MCKESSON CORPORATION
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 3 North America preventive healthcare technologies and services market, by region, 2018 - 2030 (USD Billion)
  • Table 4 U.S. preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 5 Canada preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 6 Europe preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 7 Europe preventive healthcare technologies and services market, by region, 2018 - 2030 (USD Billion)
  • Table 8 Germany preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 9 UK preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 10 France preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 11 Italy preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 12 Spain preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 13 Sweden preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 14 Norway preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 15 Denmark preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 16 Asia Pacific preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 17 Asia Pacific preventive healthcare technologies and services market, by region, 2018 - 2030 (USD Billion)
  • Table 18 China preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 19 Japan preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 20 India preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 21 Australia preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 22 Thailand preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 23 South Korea preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 24 Latin America preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 25 Latin America preventive healthcare technologies and services market, by region, 2018 - 2030 (USD Billion)
  • Table 26 Brazil preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 27 Mexico preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 28 Argentina preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 29 Middle East and Africa preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 30 Middle East and Africa preventive healthcare technologies and services market, by region, 2018 - 2030 (USD Billion)
  • Table 31 South Africa preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 32 Saudi Arabia preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 33 UAE preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 34 Kuwait preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Preventive healthcare technologies and services: market outlook
  • Fig. 9 Preventive healthcare technologies and services competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Preventive healthcare technologies and services market driver impact
  • Fig. 15 Preventive healthcare technologies and services market restraint impact
  • Fig. 16 Preventive healthcare technologies and services market strategic initiatives analysis
  • Fig. 17 Preventive healthcare technologies and services market: Type movement analysis
  • Fig. 18 Preventive healthcare technologies and services market: Type outlook and key takeaways
  • Fig. 19 Early detection & screening technologies market estimates and forecasts, (USD Billion) 2018 - 2030
  • Fig. 20 Automated screening market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 21 Personalized medicine market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 22 Other advanced screening technologies market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 23 Chronic disease management technologies market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 24 Blood pressure monitors market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 25 Asthma monitors market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 26 Cardiovascular monitors market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 27 Glucose monitors market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 28 Vaccines market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 29 Infectious diseases vaccine market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 30 Cancer vaccine market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 31 Autism vaccine market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 32 Allergy vaccine market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 33 Other new vaccines market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 34 Advanced technologies to reduce error market estimates and forecasts, (USD Billion) 2018 - 2030
  • Fig. 35 Electronic prescribing market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 36 Clinical decision supports system market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 37 Smart infusion pumps market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 38 Computerized provider order entry system market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 39 Smart packaging and automated prescription formulation and dispensing market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 40 Preventive healthcare technologies and services market: Regional movement analysis
  • Fig. 41 Preventive healthcare technologies and services market: Regional outlook and key takeaways
  • Fig. 42 North America market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 43 U.S. market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 44 Canada market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 45 Europe market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 46 UK market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 47 Germany market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 48 France market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 49 Italy market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 50 Spain market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 51 Sweden market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 52 Norway market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 53 Denmark market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 54 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 55 Japan market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 56 China market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 57 India market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 58 Australia market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 59 Thailand market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 60 South Korea market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 61 Latin America market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 62 Brazil market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 63 Mexico market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 64 Argentina market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 65 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 66 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 67 South Africa market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 68 UAE market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 69 Kuwait market estimates and forecasts, 2018 - 2030 (USD Billion)
目次
Product Code: GVR-1-68038-103-0

Preventive Healthcare Technologies And Services Market Growth & Trends:

The global preventive healthcare technologies and services market size is expected to reach USD 585.6 billion by 2030, registering a CAGR of 11.8% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Key factors driving the market expansion include the growing awareness about preventive measures, which enhance the quality of life, lifespan, and minimize the possible healthcare spending.

The growth of this market is attributed to the adoption of advanced technology and the development of preventive measures, including vaccines, screening & monitoring devices, and smart devices to reduce medical errors. Growth of the market is also fueled by factors such as reducing the birth rate that is resulting in an increase of the geriatric population, which is more prone to chronic diseases.

With the introduction of the Human Development Index (HDI) ratings since 2010, all countries are engaged in the overall development of their country and citizens. Life expectancy has a significant impact on HDI calculations. Governments of the countries have been focusing on improving life expectancy of the people by implementing various programs, including free or affordable vaccination, smoking cessation, and affordable insurance schemes. These programs cause a direct positive impact on preventable technologies and services space.

A large share of preventive healthcare includes early detection and screening technology. This segment pertains to personalized diagnostic techniques, which has captured the largest share owing to the accuracy and availability of the innovative techniques for diagnosis.

Preventive Healthcare Technologies And Services Market Report Highlights:

  • According to data published by the WHO, the percentage of the total vaccinations in the U.S. has been growing. The vaccinations included those funded by the government as well as private purchases.
  • In 2022, the early detection and screening technologies' segment captured the largest share. The advantages associated with personalized medicine technologies, such as high accuracy and detection of the possible disease or disorder at an early stage, are mainly attributed to the largest share of the segment.
  • With the introduction of advanced technology and the growing demand for accurate screening methods, the growth of early detection and screening is expected to be the fastest during the forecast period.
  • North America dominated the market with the largest revenue share of 40.4% in 2022.
  • Growing economies and government initiatives are expected to drive the growth of the Asia Pacific region. The segment is expected to witness a lucrative CAGR of over 14.2% during the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technology
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Preventive Healthcare Technologies & Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Preventive Healthcare Technologies & Services Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Preventive Healthcare Technologies & Services Market: Type Estimates & Trend Analysis

  • 4.1. Preventive Healthcare Technologies & Services Market: Key Takeaways
  • 4.2. Preventive Healthcare Technologies & Services Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Early Detection & Screening Technologies
    • 4.3.1. Early detection & screening technologies market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.3.2. Automated screening
      • 4.3.2.1. Automated screening market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.3.3. Personalized medicine
      • 4.3.3.1. Personalized medicine market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.3.4. Other advanced screening technologies
      • 4.3.4.1. Other advanced screening technologies market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.4. Chronic Disease Management Technologies
    • 4.4.1. Chronic disease management technologies market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.4.2. Blood pressure monitors
      • 4.4.2.1. Blood pressure monitors market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.4.3. Asthma monitors
      • 4.4.3.1. Asthma monitors market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.4.4. Cardiovascular monitors
      • 4.4.4.1. Cardiovascular monitors market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.4.5. Glucose monitors
      • 4.4.5.1. Glucose monitors market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.5. Vaccines
    • 4.5.1. Vaccines market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.5.2. Infectious diseases
      • 4.5.2.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.5.3. Cancer vaccine
      • 4.5.3.1. Cancer vaccine market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.5.4. Autism vaccine
      • 4.5.4.1. Autism vaccine market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.5.5. Allergy vaccine
      • 4.5.5.1. Allergy vaccine market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.5.6. Other new vaccines
      • 4.5.6.1. Other new vaccines market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.6. Advanced Technologies to Reduce Errors
    • 4.6.1. Advanced technologies to reduce errors market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.6.2. Electronic prescribing
      • 4.6.2.1. Electronic prescribing market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.6.3. Clinical decision support system
      • 4.6.3.1. Clinical decision support system market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.6.4. Smart infusion pumps
      • 4.6.4.1. Smart infusion pumps market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.6.5. Computerized provider order entry system
      • 4.6.5.1. Computerized provider order entry system market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.6.6. Smart packaging
      • 4.6.6.1. Smart packaging market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 5. Preventive Healthcare Technologies & Services Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. Preventive Healthcare Technologies & Services Market by Region: Key Takeaway
  • 5.3. North America
    • 5.3.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. UK
      • 5.4.2.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. Germany
      • 5.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. France
      • 5.4.4.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Italy
      • 5.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Spain
      • 5.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Sweden
      • 5.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Norway
      • 5.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.9. Denmark
      • 5.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. Japan
      • 5.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. China
      • 5.5.3.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. India
      • 5.5.4.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Australia
      • 5.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. Thailand
      • 5.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.7. South Korea
      • 5.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Brazil
      • 5.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Mexico
      • 5.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.4. Argentina
      • 5.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. Saudi Arabia
      • 5.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. South Africa
      • 5.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. UAE
      • 5.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.5. Kuwait
      • 5.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Market Participant Categorization
    • 6.2.1. Myriad Genetics, Inc.
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. Quest Diagnostics Incorporated
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Medtronic
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Abbott
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. Merck & Co., Inc.
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. GSK plc
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Omnicell
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. MCKESSON CORPORATION
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives